Tag archive for ‘Mylan’’
Jewish Business News On Monday, February 26th, 2018

Allergen, the Mohawk Indian Tribe and What Is the Connection to Teva

  The creative attempt by the drug company Allergan to fight generic competition by Mylan and Teva failed, and not for the first time. The appeals committee of the US Patent Office on Friday rejected an application More...

Shai Genish On Thursday, October 26th, 2017

The UK Court Overturned Teva’s Copaxone Patent

  The British Supreme Court ruled Thursday in favor of Mylan and its Dutch partner Synthon, and canceled all Teva’s Copaxone for 40 mg in the country based on obviousness. A statement by Mylan believes More...

Jewish Business News On Thursday, March 3rd, 2016

Perrigo Inaugurates $46 Million Factory in Israel

  Perrigo pharmaceutical firm opened a new factory in south of Israel, Reuters reports on Wednesday. The company invested some $45 million to expand its facility. The generic drugmaker will manufactures More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Thursday, October 22nd, 2015

Perrigo Taking Actions to Fend Off Mylan, Deliver Shareholder Value Far Superior to Mylan Offer

Perrigo, which is the target of a hostile takeover bid by Mylan, said Thursday that it would reduce its workforce by approximately 800 employees, or approximately 6 percent of its current global headcount. More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Ilan Shavit On Tuesday, October 13th, 2015

Mylan to Pitch Today to Perrigo Shareholders in Hostile Takeover Bid

  The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday,  5 pm,  conference call to pitch the buyout to Perrigo shareholders. Perrigo has rejected the $27 billion buyout More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Tuesday, September 15th, 2015

Mylan Begins $27 Billion Hostile Bid for Perrigo

  Mylan N.V. on Monday announced that it has officially took its $27 billion takeover bid directly to shareholders of Perrigo Company plc (NYSE: PRGO; TASE). In April 29th Mylan made the same offer, then More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo

Perrigo CEO: Mylan’s Propose Shows Sign of Desperation

  Perrigo Company plc (NYSE: PRGO; TASE) today responded to the announcement that Mylan N.V. has lowered the acceptance condition for its proposed unsolicited offer to acquire Perrigo from not less than 80% More...

Shiri Habib-Valdhorn On Thursday, August 13th, 2015

Mylan Might Make Do With Only 50% of Perrigo

  Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that under More...

Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva Losing $300 Million on Mylan Stake

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...

Niva Goldberg On Thursday, July 23rd, 2015

Three Ways Takeover Battle: Mylan Invokes “Poison Pill” To Block Teva Hostile Takeover

  Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the Call Option Agreement, dated April 3, 2015, between More...


Delivered by FeedBurner